Utama › Kanser Salur Empedu (Kolangiokarsinoma) › New York › New York City
Kajian klinikal Kanser Salur Empedu (Kolangiokarsinoma) di New York City, NY
11 kajian untuk Kanser Salur Empedu (Kolangiokarsinoma) sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of PHST001 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- Mount Sinai, New York
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Cancer Center (Site 108), New York
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Mengambil pesertaFasa 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Mengambil pesertaFasa 3
- Memorial Sloan Kettering Cancer Centers, New York
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Mengambil pesertaFasa 1/2
- New York University Langone Health, New York
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Cancer Center, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
Mengambil pesertaFasa 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Icahn School of Medicine at Mt. Sinai, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, New York
The Dragon PLC Trial (DRAGON-PLC)
Mengambil peserta
- Memorial Sloan Kettering Cancer Center, New York
Kajian Kanser Salur Empedu (Kolangiokarsinoma) di bandar lain
- Houston, TX13 kajian
- Boston, MA8 kajian
- Rochester, MN7 kajian
- Arlington, VA7 kajian
- Los Angeles, CA7 kajian
- Chicago, IL7 kajian
- Columbus, OH6 kajian
- Cleveland, OH6 kajian
- Edison, NJ5 kajian
- Queens, NY5 kajian
- Grand Rapids, MI5 kajian
- Nashville, TN5 kajian
Kajian lain di New York City
- Kanser Payudara136 kajian
- Kanser Paru-paru Bukan Sel Kecil121 kajian
- Kanser (semua jenis)109 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal78 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Pankreas60 kajian
- Kanser Endometrium52 kajian
- Leukemia Mieloid Akut51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.